MacroGenics, Inc.

MacroGenics, Inc.

MacroGenics, Inc.

MG has the capabilities to discover, develop and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases.
Founded
2000
Raised
$45M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Team Size
50+
Employees
the home of AI info

Comparing of MacroGenics Inc. (MGNX) and Minerva Neurosciences Inc. (NASDAQ:NERV)

MedCity News

FDA places hold on MacroGenics' bispecific antibody trials over liver toxicity concerns

The Motley Fool

Why Charter Communications, MacroGenics, and TD Ameritrade Jumped Today

Stock markets